Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA
- PMID: 35569538
- DOI: 10.1016/j.envres.2022.113431
Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA
Abstract
Per- and polyfluoroalkyl substances (PFAS) are highly persistent, manufactured chemicals used in various manufacturing processes and found in numerous commercial products. With over 9000 compounds belonging to this chemical class, there is increasing concern regarding human exposure to these compounds due to their persistent, bioaccumulative, and toxic nature. Human exposure to PFAS may occur from a variety of exposure sources, including, air, food, indoor dust, soil, water, from the transfer of PFAS from non-stick wrappers to food, use of cosmetics, and other personal care products. This critical review presents recent research on the health-related impacts of PFAS exposure, highlighting compounds other than Perfluorooctanoic acid (PFOA) and Perfluoroctane sulfonate (PFOS) that cause adverse health effects, updates the current state of knowledge on PFAS toxicity, and, where possible, elucidates cause-and-effect relationships. Recent reviews identified that exposure to PFAS was associated with adverse health impacts on female and male fertility, metabolism in pregnancy, endocrine function including pancreatic dysfunction and risk of developing Type 2 diabetes, lipid metabolism and risk of childhood adiposity, hepatic and renal function, immune function, cardiovascular health (atherosclerosis), bone health including risk for dental cavities, osteoporosis, and vitamin D deficiency, neurological function, and risk of developing breast cancer. However, while cause-and-effect relationships for many of these outcomes were not able to be clearly elucidated, it was identified that 1) the evidence derived from both animal models and humans suggested that PFAS may exert harmful impacts on both animals and humans, however extrapolating data from animal to human studies was complicated due to differences in exposure/elimination kinetics, 2) PFAS precursor kinetics and toxicity mechanism data are still limited despite ongoing exposures, and 3) studies in humans, which provide contrasting results require further investigation of the long-term-exposed population to better evaluate the biological toxicity of chronic exposure to PFAS.
Keywords: Health effects; Human health; PFAS; Per- and polyfluoroalkyl substances; Toxicity.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
United States Environmental Protection Agency's Perfluorooctanoic Acid, Perfluorooctane Sulfonic Acid, and Related Per- and Polyfluoroalkyl Substances 2024 Drinking Water Maximum Contaminant Level: Part 2 - Fifteen Misconceptions About the Health Hazards.Crit Rev Toxicol. 2025;55(3):368-415. doi: 10.1080/10408444.2024.2446453. Epub 2025 May 20. Crit Rev Toxicol. 2025. PMID: 40391660 Review.
-
Characteristic and human exposure risk assessment of per- and polyfluoroalkyl substances: A study based on indoor dust and drinking water in China.Environ Pollut. 2019 Nov;254(Pt A):112873. doi: 10.1016/j.envpol.2019.07.041. Epub 2019 Jul 18. Environ Pollut. 2019. PMID: 31369910
-
Concentration and health risk assessment of per- and polyfluoroalkyl substances in cosmetic and personal care products.J Environ Sci Health B. 2024;59(9):551-561. doi: 10.1080/03601234.2024.2384234. Epub 2024 Aug 13. J Environ Sci Health B. 2024. PMID: 39138893
-
Maternal exposure to legacy PFAS compounds PFOA and PFOS is associated with disrupted cytokine homeostasis in neonates: The Upstate KIDS study (2008-2010).Environ Int. 2025 Feb;196:109288. doi: 10.1016/j.envint.2025.109288. Epub 2025 Jan 16. Environ Int. 2025. PMID: 39848095
-
Per- and polyfluoroalkyl substances: toxicokinetics, exposure and health risks.J Toxicol Sci. 2025;50(3):97-104. doi: 10.2131/jts.50.97. J Toxicol Sci. 2025. PMID: 40024759 Review.
Cited by
-
Personal Strategies to Reduce the Cardiovascular Impacts of Environmental Exposures.Circ Res. 2024 Apr 26;134(9):1197-1217. doi: 10.1161/CIRCRESAHA.123.323624. Epub 2024 Apr 25. Circ Res. 2024. PMID: 38662863 Free PMC article. Review.
-
Exploring the relationship between per- and polyfluoroalkyl substances exposure and rheumatoid arthritis risk using interpretable machine learning.Front Public Health. 2025 Jun 3;13:1581717. doi: 10.3389/fpubh.2025.1581717. eCollection 2025. Front Public Health. 2025. PMID: 40529687 Free PMC article.
-
Novel and legacy per- and polyfluoroalkyl substances in humans: Long-term temporal variability and metabolic perturbations.Environ Int. 2025 Jul;201:109590. doi: 10.1016/j.envint.2025.109590. Epub 2025 Jun 6. Environ Int. 2025. PMID: 40516284
-
Sex differences in ischemic heart disease and evidence gathering related to exposure risk, prevention, and treatment of per- and poly-fluoroalkyl substances.Front Public Health. 2025 Jun 20;13:1596125. doi: 10.3389/fpubh.2025.1596125. eCollection 2025. Front Public Health. 2025. PMID: 40620566 Free PMC article.
-
New QSAR Models to Predict Human Transthyretin Disruption by Per- and Polyfluoroalkyl Substances (PFAS): Development and Application.Toxics. 2025 Jul 14;13(7):590. doi: 10.3390/toxics13070590. Toxics. 2025. PMID: 40711034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical